{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16"],"submitter":["Sarc I"],"pubmed_abstract":["<h4>Background</h4>Previous studies have suggested that the coronavirus disease 2019 (COVID-19) pandemic was associated with a decreased rate of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Data on how the COVID-19 pandemic has influenced mortality, seasonality of, and susceptibility to AECOPD in the chronic obstructive pulmonary disease (COPD) population is scarce.<h4>Methods</h4>We conducted a national population-based retrospective study using data from the Health Insurance Institute of Slovenia from 2015 to February 2021, with 2015-2019 as the reference. We extracted patient and healthcare data for AECOPD, dividing AECOPD into severe, resulting in hospitalisation, and moderate, requiring outpatient care. The national COPD population was generated based on dispe"],"journal":["Therapeutic advances in respiratory disease"],"pagination":["17534666221081047"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8905064"],"repository":["biostudies-literature"],"pubmed_title":["Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study."],"pmcid":["PMC8905064"],"pubmed_authors":["Sambt J","Ziherl K","Sarc I","Selb J","Morgan T","Gavric D","Dosenovic Bonca P","Lotric Dolinar A","Rozman A"],"additional_accession":[]},"is_claimable":false,"name":"Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study.","description":"<h4>Background</h4>Previous studies have suggested that the coronavirus disease 2019 (COVID-19) pandemic was associated with a decreased rate of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Data on how the COVID-19 pandemic has influenced mortality, seasonality of, and susceptibility to AECOPD in the chronic obstructive pulmonary disease (COPD) population is scarce.<h4>Methods</h4>We conducted a national population-based retrospective study using data from the Health Insurance Institute of Slovenia from 2015 to February 2021, with 2015-2019 as the reference. We extracted patient and healthcare data for AECOPD, dividing AECOPD into severe, resulting in hospitalisation, and moderate, requiring outpatient care. The national COPD population was generated based on dispe","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan-Dec","modification":"2025-04-26T04:05:34.881Z","creation":"2025-04-06T10:58:10.178Z"},"accession":"S-EPMC8905064","cross_references":{"pubmed":["35253548"],"doi":["10.1177/17534666221081047"]}}